Snuza® announces partnership with The Lullaby Trust

Snuza®, the manufacturer of the Snuza HeroMD – the world’s first medically certified wearable breathing monitor, is delighted to announce a partnership with The Lullaby Trust, the leading charity for the prevention of sudden infant death syndrome (SIDS) and support for parents bereaved by the sudden unexpected death of a baby.
The partnership, driven by Snuza UK distributor Nimans Home, focuses on the CONI programme, which provides support for bereaved parents who go on to have another baby. Parents who have experienced a sudden and unexpected death of a child often feel anxious when they have another baby. The Lullaby Trust works with the local providers of public healthcare services to coordinate a national health-visitor led service for bereaved parents This includes regular contact with their health visitor, so they can talk freely about any worries and seek advice and training on basic life support, so parents will know what to do if their baby stops breathing. Symptom diaries and weight charts are provided to detect changes that may mean baby should be checked by a doctor.
“Following the death of Joe, when I fell pregnant with Alfie I was obviously delighted, but extremely anxious. The CONI programme was a tremendous support. I couldn’t have coped without it.” – Tracey, South London
In addition, the CONI programme also makes it possible to borrow specialist monitors, which pick up changes in baby’s breathing, and will ring an alarm if breathing stops for longer than 20 seconds, to provide extra reassurance. Snuza have donated Snuza HeroMD monitors to the CONI programme which are accessible to bereaved parents in order to provide a little comfort for the first few months when their new baby is home.
The Snuza HeroMD Infant Breathing Monitor is a wearable device which attaches to baby’s nappy and monitors their breathing. If the Snuza HeroMD detects no breathing for 15 seconds it will vibrate in an effort to rouse baby to resume breathing . Often the vibration is enough to rouse the infant and the HeroMD will revert to monitoring mode. However, after three vibration/rousing incidents, a Rouse Warning will alert parents that breathing has not been detected for 15 seconds on three occasions. If an additional 5 seconds of no breathing is detected a sharp audible alarm will sound.
The Snuza HeroMD holds the Medical Device Certification for European Directive 93/42/EEC which means Snuza are the first company in the World to bring a fully certified Class IIb wearable infant breathing monitor onto the European market.
Rebecca Fuchs of Nimans Home says: “We are thrilled to support The Lullaby Trust and the valuable work they do. The Snuza monitor is so reassuring for parents and especially so for those having a rainbow baby. We are so pleased to embark on this partnership and support parents in such a worrying time”
“We are delighted to be working in partnership with Snuza” says Jenny Ward Chief Executive of The Lullaby Trust. “The donation of monitors means we will be able to support many more bereaved parents through the CONI programme, providing peace of mind and allowing parents to enjoy those precious first weeks and months with their new baby.”
“Being certified to the EU Medical Device Directives provides the necessary level of quality and proven efficacy that customers and patients should expect, given the nature of the function these Devices perform. Being the only wearable such Device, we are extremely excited to be part of this worthy programme where parents may welcome the benefits of our proven technology in a small and compact product” says Greg Gallagher CEO and Founder of Snuza.